MedNet.nl: The optimal treatment of relapsed and refractory (R/R) peripheral T-cell lymphoma (PTCL) is as yet unknown. Dutch population-based research provides insight into the most commonly used treatment strategies for this patient group.
22-06-2023 | Non-Hodgkin Lymphoma | Congress News | News
EHA 2023